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Abstract
Background: Unlike pharmaceuticals and private medical services there is no single source of
funding for illness prevention and health promotion and no systematic process for setting priorities
in public health. There is a need to improve the efficiency of access to health funding across
prevention and treatment.
Discussion: We discuss a number of reforms to existing funding arrangements including the
creation of a national Preventative Priorities Advisory Committee (PrePAC) to set priorities. We
propose the establishment of a PrePAC to provide evidence and set priorities across health
promotion and illness prevention, with a national dedicated fund for health promotion.
Conclusion:  A national evidence-based funding system for illness prevention and health
promotion would legitimise a substantial and sustained budget for health promotion, breaking
down some of the barriers in a fragmented federal health care system.
Background
Funding for illness prevention and health promotion in
Australia is fragmented. Programs are funded by federal,
state and local government but a lack of coordination and
priority setting means that we are not making a consid-
ered allocation of resources to illness prevention and
health promotion. We neither choose how much to spend
compared to other health care activities, nor do we choose
interventions that offer the best value. Australia has led
the world in introducing formal evidence-based evalua-
tion processes for medical services and technologies to
establish value for money, but, as a consequence of frag-
mented responsibility and funding, health promotion
and illness prevention have been left out. While pharma-
ceuticals and (out of hospital and private hospital) medi-
cal services in Australia have access to dedicated budgets
and are subject to formal and well-defined evaluation
processes, most prevention and health promotion inter-
ventions compete for disparate and uncertain sources of
funding that lack consistent and rational criteria for allo-
cation. In Australia, differences in the likelihood of fund-
ing among otherwise equivalent interventions can be
attributed partly to differences in funding arrangements
[1]. An efficient health care system would not discrimi-
nate in this way. In this paper we suggest the creation of a
national Preventative Priorities Advisory Committee (Pre-
PAC) to reduce the gap in the likelihood of obtaining
public funding among equally cost effective interventions.
Discussion
Two Models for a PrePAC
Two stylised models for the operation of a PrePAC are
considered here: a (i) Guidance Model and a (ii) Dedi-
cated Funding Model.
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Guidance model
The UK National Institute of Clinical Excellence (NICE)
provides evidence-based guidance relating to health tech-
nologies and public health interventions [2-4]. The Public
Health Interventions Advisory Committee (PHIAC) and
Technology Appraisal Committees of NICE produce rec-
ommendations on the use of public health interventions
and health technologies--based on consideration of the
available evidence regarding effectiveness and the cost
effectiveness. Under the guidance model, a proposed Pre-
PAC would take a similar role to that of the PHIAC in Eng-
land. It would take account of the strength of evidence on
effectiveness and cost effectiveness of a prevention activity
and might, for example, provide guidance that a particular
activity should be given higher or lower priority. While
the quality of evidence in the area of prevention is often
not high, this is not necessarily a barrier to good decision-
making [5]. It would produce a list of recommendations
that funding agencies could take into account when mak-
ing funding decisions and setting priorities for preven-
tion. In 2009, COAG agreed to fund such a national
preventive health agency with responsibility for providing
evidence-based policy advice [6]; this model was
endorsed by both the National Health and Hospital
Reform Commission [7] and the Preventative Health
Taskforce [8].
The main problem with a guidance model is that there is
no mechanism for funding. The guidance model relies on
a disparate set of independent funding agencies to imple-
ment PrePAC deliberations and recommendations. While
the various responsible funding agencies might modify
their own funding rules or processes to take account of
PrePAC deliberations and recommendations, such recom-
mendations would be neither necessary nor sufficient to
secure funding. There may be no new funding allocated
for prevention and no guarantee that the deliberations
and recommendations of a PrePAC will have any impact
at all upon resource allocation. Implementation involves
much more than simply developing and disseminating
guidance. The Guidance model therefore falls well-short
of giving preventative interventions an equal chance of
funding compared to otherwise equivalent interventions
that benefit from access to a well-defined funding mecha-
nism.
Dedicated Prevention Fund
A PrePAC allocating a dedicated prevention fund could be
modelled on the operation of the Medical Services Advi-
sory Committee (MSAC) [9] or the Pharmaceutical Bene-
fits Advisory Committee (PBAC) in Australia [10].
Specifically, a PrePAC would advise a fund-holder on
whether a particular intervention or program should be
allocated money from a dedicated prevention fund. Rec-
ommendations accepted by the fund-holder would then
be listed on a Prevention Benefits Schedule (PreBS).
Depending on funding arrangements, the fund-holder
might be one or more of the Australian Health Ministers.
For clinical prevention services provided by a registered
provider to an individual patient, the PreBS could operate
in much the same way as individual patient benefits listed
on the Medicare Benefits Schedule (MBS) or the Pharma-
ceutical Benefits Schedule (PBS). That is to say, there
would be a list of interventions approved for funding
from the scheme on a per-service (e.g. individual consul-
tation on diet or smoking behaviour) or per-patient basis
(e.g. annual enrolment in a disease management pro-
gram).
Following Goldsmith et al. [11], we distinguish clinical
prevention from non-clinical preventative interventions
such as: (i) health promotion that targets a population to
encourage healthy behaviour and is provided by govern-
ment or interest group organisations, (ii) health protec-
tion that reduces health risk by changing the physical or
social environment often by regulation, and (iii) healthy
public policy that involves social or economic interven-
tions beyond the health sector. Individual patient benefits
may be unsuitable for funding these categories of non-
clinical prevention and alternative mechanisms would
need to be used. For example, payments for health pro-
motion interventions might be based on a list of lump-
sum grants to cover a delimited set of activities over a
defined time period. Examples might include: annual
budget allocation to organisation(s) responsible for deliv-
ery of mass media education campaigns on road safety,
healthy eating, physical activity, alcohol consumption, or
smoking cessation; lump sum payment to local councils
or community organisations for community events to
promote community connectedness, safe communities or
healthy lifestyle; or lump sum payment to schools for the
establishment of programs to promote healthy lifestyle
such as the walking school bus or sex education.
For healthy public policy and health protection interven-
tions, the PreBS could be a list of lump-sum grants to
cover a delimited set of activities at a specific geographic
location. Examples might include: lump sum payment to
local councils, state governments or community organisa-
tions to alter the physical environment either to promote
healthy lifestyle (such as the provision of walking tracks/
pedestrian crossings, or improvements to parks and recre-
ation areas) or to improve safety (provision of street signs
near school crossings or provision of lighting or CCTV
around train stations or shopping precincts); lump sum
payment to schools to alter the physical environment to
promote healthy lifestyle (such as establishment of a
kitchen garden or sporting facilities); lump sum payment
to schools to alter the social environment to improve
safety (such as provision of interventions to reduce bully-
ing).Australia and New Zealand Health Policy 2009, 6:25 http://www.anzhealthpolicy.com/content/6/1/25
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Reimbursement via lump sum payments and annual
budget allocations is no different in principle than per-
service or per-patient payments. In each case evaluation of
the safety, effectiveness and cost effectiveness of all pre-
ventative interventions would be for an approved indica-
tion and scale. For clinical prevention, the indication
would typically relate to characteristics of the patient and
the provider. For example, provision of group exercise ses-
sions might only provide good value for money in people
with diabetes or cardiovascular disease if they are predom-
inantly focused on cardiovascular fitness (rather than
strength or flexibility training). For health promotion and
health protection interventions, the indication might
instead relate to characteristics of the community. Provi-
sion of CCTV around train stations might only provide
good value for money in areas that have a high level of
street crime.
The PrePAC might therefore approve open-ended funding
for a listed item in much the same way as the PBAC or
MSAC, specifying an approved indication for each item.
For clinical prevention, claims for PreBS items might fol-
low similar procedures as for restricted benefit items on
the PBS. The PrePAC might, however, choose to specify
"pre-approval" status for some types of interventions; par-
ticularly for health promotion and health protection
interventions that entail relatively large lump sum pay-
ments. Obtaining approval might require submission of
evidence to substantiate that the intended use of funds
meets the restriction for the relevant item number. For
example, a council requesting funding for a pedestrian
crossing might be required to provide traffic impact anal-
yses, a community survey demonstrating community sup-
port, and an assessment of the impact of community
structure on access to community nodes. Provision of
funding for a specific pedestrian crossing with authority
required status would therefore entail a two-stage process.
First, the PrePAC would have to list pedestrian crossings
on the schedule for an approved 'indication'. Second, the
local council requesting funding for a specific pedestrian
crossing would have to submit a request for approval
demonstrating that the intended site meets the 'approved
indication' and that the intervention conforms with the
approved description in terms of its active constituent
parts delivered effectively.
While the dedicated fund model has the advantage of sim-
plicity and familiarity it does have a few boundary issues
that would need to be resolved. Regulatory or infrastruc-
ture interventions may not sit easily in a health system
funding scheme. Smoking or alcohol regulation or the
provision of public transport could be appraised by a Pre-
PAC but it is more difficult to imagine a PreBS with the
capability to facilitate legislative change or to provide the
necessary funding incentives for major infrastructure
developments.
A proposal for reform
Currently clinical prevention is partially covered under
existing programs (such as the MBS, PBS, and NIP). Other
prevention and health promotion activities are more or
less covered by one of a multiplicity of government (fed-
eral, state and local) and non-government organisations
(such as the National Heart Foundation and Cancer
Councils). Health protection and healthy public policy
are currently handled within the relevant departments of
federal, state or local governments. We propose reforms to
existing funding arrangements that take account of the
current state of play while increasing the efficiency of
access to health funding across prevention and treatment.
Specifically, we propose a PrePAC providing guidance
with regard to health promotion, health protection and
healthy public policy, but that relies on existing programs
(such as the MBS, PBS, and NIP) to provide guidance and
funding for clinical prevention. Delimiting the scope of a
PrePAC in this way would capture the majority of inter-
ventions while minimising the risk of replicating the func-
tion of existing agencies. Gaps in the coverage of clinical
prevention would then be handled by modifying the
scope of services covered under existing programs by, for
example, issuing Medicare Provider Numbers to a broader
range of health care providers and adding item numbers
to the MBS. Given the multiplicity of parties currently
involved in appraisal of health promotion, health protec-
tion and healthy public policy (in contrast to the relatively
small number of agencies with responsibility for clinical
prevention), the creation of a PrePAC would yield sub-
stantial cost savings and improvements in the consistency
and quality of evidence appraisals.
For health promotion, we believe that the PrePAC should
be extended beyond the guidance model to allocate a
national fund for health promotion activities. The crea-
tion of a PrePAC with responsibility for funding health
promotion has the potential to reduce the number of pro-
grams making allocation decisions and can be expected to
improve the consistency and quality of decision-making.
A PrePBS would provide national coverage of health pro-
motion activities and a clear pathway for funding for
interventions that currently have no obvious source of
funding.
While we believe that a PrePAC could make a valuable
contribution by providing guidance for non-clinical pre-
vention, many preventative interventions that might be
categorised as health protection and healthy public policy
would not be amenable to funding through an item based
PreBS-type mechanism. The large-scale inter-sectoral
nature of some health protection and healthy public pol-Publish with BioMed Central    and   every 
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icy interventions (such as transport and infrastructure)
and the non-financial costs of implementing of others
(such as smoking restrictions) are not easily achieved
through the allocation of a dedicated fund. For this rea-
son, we propose that the PrePAC should initially provide
guidance only for health protection and healthy public
policy.
Conclusion
We agree with the Wanless report [12] that "to achieve the
objective of an efficient allocation of national health serv-
ice funding between health care and public health, a sim-
ilar method of cost effectiveness analysis needs to be
applied to public health and clinical interventions." Our
suggestion is to create a new body--the Prevention Priori-
ties Advisory Committee (PrePAC). The PrePAC would
provide advice on the effectiveness and cost effectiveness
of interventions in health protection and healthy public
policy. This is consistent with aspects of other proposals
to establish a nationally coordinated preventive health
agency responsible for the evaluation of effectiveness, effi-
ciency and equity outcomes [6,8,13]. It has the potential
to engage many of the levers identified by Lin [14] for
shifting the focus of the health system to more emphasis
on prevention and health promotion. We believe that it is
necessary to go further and establish a national dedicated
fund for health promotion, access to which would be
determined by the PrePAC. This would provide a national
program, thus breaking down some of the barriers in a
fragmented federal health care system. It would provide
technical leadership and a political voice for prevention
that has been lacking compared to medical services and
pharmaceuticals. Perhaps most importantly it would
legitimise a substantial sustained budget for health pro-
motion that would be directly translated into policy
choices. In doing so it has the potential to improve the
efficiency and equity of the overall health care system.
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